HLA-DR3: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 30: | Line 30: | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
<gallery> | |||
File:DR Illustration.PNG|DR Illustration | |||
</gallery> | |||
Latest revision as of 05:25, 3 March 2025
HLA-DR3 is a human leukocyte antigen serotype within the HLA-DR serotype group. The serotype is determined by the antibody recognition of antigens. HLA-DR3 is a split antigen of the broad antigen HLA-DR17, which is now obsolete. HLA-DR3 is associated with several autoimmune diseases, including type 1 diabetes, coeliac disease, and systemic lupus erythematosus.
Structure and Function[edit]
HLA-DR3 is a cell surface glycoprotein that plays a crucial role in the immune system. It is part of the major histocompatibility complex (MHC) class II, which presents antigens to the T cells. The HLA-DR3 antigen is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane.
Disease Associations[edit]
HLA-DR3 is associated with a variety of autoimmune diseases. These include:
- Type 1 diabetes: HLA-DR3 and HLA-DR4 are the most common serotypes associated with this disease. The presence of these serotypes increases the risk of developing type 1 diabetes.
- Coeliac disease: HLA-DR3 is found in up to 95% of patients with coeliac disease. The presence of HLA-DR3 is a strong predictor of the development of coeliac disease.
- Systemic lupus erythematosus: HLA-DR3 is associated with an increased risk of developing systemic lupus erythematosus, particularly in individuals of European descent.
See Also[edit]
References[edit]
<references />
-
DR Illustration
